AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection

NACompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Arrhythmias, CardiacAtrial FibrillationAtrial FlutterBradycardiaTachycardia
Interventions
DEVICE

Vectorcardiography (VECG)

Patients enrolled will undergo diagnostic ECG recording: three sets of simultaneous 30s recordings with the investigational device AIMIGo and a standard 12L ECG.

Trial Locations (5)

10029

The Mount Sinai Hospital, New York

11040

Long Island Jewish Medical Center, Queens

15212

Allegheny Health Network, Pittsburgh

30084

Atlanta Heart Specialists, Tucker

30309

Piedmont Heart Institute, Atlanta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

HeartBeam, Inc.

INDUSTRY